p53 is a pivotal molecule regulating the death of neurons both after acute injury and during development. The molecular mechanisms by which p53 induces apoptosis in neuronal cells, however, are not well understood. We have shown previously that adenovirus-mediated p53 gene delivery to neurons was sufficient to induce apoptosis. In the present study we have examined the molecular mechanism by which p53 evokes neuronal cell death. Adenovirus-mediated delivery of p53 to cerebellar granule neurons resulted in caspase-3 (CPP32) activation followed by terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) staining and loss of viability as determined by an MTT survival assay. To determine whether Bax is essential for caspase-3 activation, p53 was expressed in Bax-deficient cells. Bax null neurons did not exhibit caspase-3 activation in response to p53 and were protected from apoptosis. To determine whether Bax-dependent caspase-3 activation was required in p53-mediated neuronal cell death, caspase-3-deficient neurons were examined. Our results indicate that caspase-3-deficient neurons exhibit a remarkable delay in apoptosis and a dramatic decrease in TUNEL-positive cells. These studies demonstrate that p53-induced cell death in postmitotic neurons involves a Baxdependent caspase-3 activation, suggesting that these molecules are important determinants in neuronal cell death after injury.
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Apoptosis is a biological process that plays a crucial role in nervous system development and injury. During development, cell death is essential for the regulation of neuronal cell number as well as protection against the f urther propagation of aberrant cells (Oppenheim, 1991; Henderson, 1996) . In the mature nervous system, inappropriate cell death is implicated as an underlying defect in many types of neurodegeneration (PorteraCailliau et al., 1995; Smale et al., 1995; Thompson, 1995) as well as acute neurological insults (Linnik et al., 1993; MacManus et al., 1993; Li et al., 1995; Nitatori et al., 1995; Rink et al., 1995) . Understanding the molecular events triggering apoptosis, therefore, is an important step toward the development of effective treatment strategies for such neurological diseases.
The p53 tumor suppressor gene is involved in the regulation of apoptosis in a number of different paradigms. As a tumor suppressor, the best understood f unction for p53 is to mediate cell cycle arrest or apoptosis after DNA damage, thereby preventing the propagation of damaged cells (for review, see Ko and Prives, 1996) . Aberrant cell cycle regulation during development, such as the widespread CNS defect in Rb null transgenic mice, evokes a p53-mediated apoptosis (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . More recently, p53 has also been found to play an essential role in developmental neuronal cell death as regulated by the TrkA and p75 neurotrophin receptors (Aloyz et al., 1998) . In the mature nervous system, p53 has been implicated as a key regulatory molecule after neuronal injury (for review, see Hughes et al., 1997) . Brain damage induced by ischemia or kainic acid excitotoxicity has been shown to be significantly reduced in mice carrying a null mutation for the p53 gene (Crumrine et al., 1994; Morrison et al., 1996) . In addition, cultured neurons derived from p53-deficient mice have been shown to be resistant to excitotoxic cell death induced by either glutamate or kainic acid (Xiang et al., 1996 (Xiang et al., , 1998 . Enhanced expression of p53 has been observed in injured neurons before cell death induced by focal ischemia (Chopp et al., 1992; Li et al., 1994; McGahan et al., 1998) , excitotoxicity (Sakhi et al., 1996; Uberti et al., 1998) , and hypoxia (Banasiak and Haddad, 1998) . Finally, it has been demonstrated that p53 overexpression itself is sufficient to trigger apoptosis in primary cultures of cortical, hippocampal, and sympathetic neurons Xiang et al., 1996; Jordan et al., 1997) . Although these studies strongly implicate p53 as a key molecular switch leading to the death of injured neurons, the mechanism by which p53 triggers this apoptotic response is not well understood.
The signaling cascade induced by p53 is complex and likely differs depending on the type of tissue examined (for review, see Ko and Prives, 1996; Ding and Fisher, 1998) . There is some evidence suggesting that Bax, a proapoptotic member of the bcl-2 family of cell death-regulating genes, may be involved in p53-induced apoptosis. The Bax gene contains p53 consensus sequences within its promoter and has been shown to be transcriptionally regulated by p53 Miyashita and Reed, 1995) . Furthermore, Bax induction has been observed during p53-mediated cell death in a number of non-neuronal cell systems (Selvakumaran et al., 1994; Z han et al., 1994; Brady et al., 1996) . In neuronal cells the role of Bax in p53-induced apoptosis remains unclear; however, it appears to be important in a number of different neuronal death paradigms (Deckwerth et al., 1996; Miller et al., 1997; Johnson et al., 1998; X iang et al., 1998) .
One set of molecules that appear to be modulated by the presence of Bax are the caspases Martinou et al., 1998) . C aspases, a family of cysteine proteases implicated in the commitment and execution of apoptotic cell death, exist as proenzymes until cleaved in response to apoptotic stimuli (for review, see Thornberry and Lazebnik, 1998) . Recent reports indicate that caspases may play a role in neuronal cell death during development (Kuida et al., 1996 (Kuida et al., , 1998 Woo et al., 1998) as well as after neuronal injury (L oddick et al., 1996; Gillardon et al., 1997; Gottron et al., 1997; Hara et al., 1997; Cheng et al., 1998; Endres et al., 1998; Ni et al., 1998; Park et al., 1998) .
To examine the molecular cascade by which p53 induces neuronal cell death, we have used primary cultures of cerebellar granule neurons (CGNs) derived from transgenic mice carrying null mutations for either the Bax or the caspase-3 gene (CPP32). By using adenovirus-mediated p53 gene delivery to primary neuronal cells, we demonstrate that neuronal apoptosis induced by p53 is mediated by Bax and caspase-3.
MATERIALS AND METHODS
Transgenic mice. Bax-deficient transgenic mice were generously provided by Dr. Stanley Korsmeyer (Knudson et al., 1995) and are now available from Jackson Laboratories (Bar Harbor, M E). Bax mice were originally on a mixed 129/C57BL6 strain (Knudson et al., 1995) but have since been backcrossed to C57BL6 (12-14 times) and can therefore be considered a C57BL6 genetic background. Transgenic mice carrying a caspase-3 null mutation were obtained from Dr. Don Nicholson (Merck Frosst, C anada) (E. Keramis and D. S. Park, unpublished observations). The phenotype of the caspase-3-deficient mice used in these experiments was similar to those described previously (Kuida et al., 1996; Woo et al., 1998) . All caspase-3-deficient mice were maintained on a C57BL6 background to maintain genetic uniformity. Bax null mice were genotyped as described previously (Knudson et al., 1995) . C aspase-3 null mice were genotyped by PCR according to the following protocol. The usual PCR reaction buffer contained 2.25 mM MgC l 2 and 5% DMSO. The primers for the wild-type caspase-3 alleles were C TAAGTTAACCAAAGT-GAGCACCGA (sense) and ATGAATCAAGGCAGCATAGTAC TCC (antisense). For detection of the targeted allele, the same sense primer and the following antisense primer GTCGATCCAC TAGTTC TA-GAGCGGC (LZ1) were used. Conditions were set as follows: 94°C, 2 min (1 cycle); 94°C, 30 sec, 60°C, 1 min, 72°C, 1 min (30 cycles); 72°C, 5 min (1 cycle). Cell culture. Transgenic pups were genotyped at postnatal day 4 -6, after which the appropriate animals were selected for experimentation, and neurons were cultured from brains individually. Primary cultures of cerebellar granule neurons were obtained from dissociated cerebella of postnatal day 8 or 9 mice, as described previously (Levi et al., 1984; Miller and Johnson, 1996) with some modifications. Brains were removed and placed into separate dishes containing solution A (124 mM NaC l, 5.37 mM KC l, 1 mM NaH 2 PO 4 , 1.2 mM MgSO 4 , 14.5 mM D-(ϩ)-glucose, 25 mM H EPES, 3 mg /ml BSA, pH 7.4) in which the cerebella were dissected, meninges removed, and tissue sliced into small pieces. Tissue was briefly centrif uged and transferred to solution A containing 0.25 mg /ml trypsin, then incubated at 37°C for 18 min. After the addition of 0.082 mg /ml trypsin inhibitor (Boehringer Mannheim, Indianapolis, I N) and 0.25 mg /ml DNase I (Boehringer Mannheim), tissue was incubated at 25°C for 2 min. After a brief centrif ugation, the resulting pellet was gently triturated in solution A yielding suspension that was f urther incubated for 10 min at 25°C in solution A containing 2.7 mM MgSO 4 and 0.03 mM CaCl 2. After a final centrif ugation the pellet was resuspended in EM EM media (Sigma, St. L ouis, MO) containing 10% dialyzed FBS (Sigma), 25 mM KC l, 2 mM glutamine (Life Technologies BRL, Gaithersburg, MD), 25 mM glucose, and 0.1 mg /ml gentamycin (Sigma) and filtered through a cell strainer (size 70 m; Falcon). C ells were plated at a density of 1.5 ϫ 10 6 cells per milliliter of medium on either Nunc four-well or 35 ϫ 10 mm dishes (Life Technologies BRL) coated with poly-D-lysine (Sigma). C ytosine-␤-arabinoside (10 M; Sigma) was added 24 hr after plating. Recombinant adenovirus infection. Recombinant adenovirus vectors carrying the human p53 or LacZ expression cassettes were kindly provided by Dr. Frank Graham (McMaster University, Hamilton, Ontario) (Bacchetti and Graham, 1993) . In preliminary studies it was determined that treatment of cells with recombinant adenovirus vectors at a multiplicity of infection (MOI) of 50 pf u /cell resulted in a high degree of transgene expression (as shown by X-gal staining) with minimal toxicity; thus all f urther experiments were performed at this titer. Recombinant adenovirus vectors were added to cell suspensions immediately before plating. Cell survival assay. T wo different assays were used to measure cell survival: TUN EL labeling and a quantitative MTT assay. The colorimetric MTT survival assay (C ell Titer K it, Promega, Madison, W I) that measures the mitochondrial conversion of the tetrazolium salt to a blue formizan salt was used as described previously . To assay apoptosis, TUN EL labeling was used to visualize cells with fragmented DNA. C ells were harvested 72 and 96 hr after p53 or LacZ gene delivery and fixed in 4% paraformaldehyde for 10 min followed by acetone/methanol (1:1) for 1 min. C ells were then washed in three changes of PBS and incubated for 1 hr at 37°C with 75 l of a mixture (Boehringer Mannheim) consisting of 0.5 l terminal transferase, 0.95 l biotin-16-dUTP, 6.0 l CoCl 2 , 15.0 l 5 ϫ TdT buffer, and 52.55 l distilled water. C ells were then washed three times in PBS and incubated with a streptavidin C y2 secondary antibody (Jackson Immunoresearch Laboratories, West Grove, PA). C ells were counterstained with Hoechst 33258, and the fraction of TUN EL -positive cells was determined. A minimum of 500 cells was scored for each treatment, and the data represent the mean of three independent experiments.
Caspase protease activit y assays. C ells were harvested and extracted for 15 min on ice in a lysis buffer consisting of 1 mM KC l, 10 mM H EPES, pH 7.4, 1.5 mM MgC l 2 , 1 mM DTT, 1 mM PMSF, 5 g /ml leupeptin, 2 g /ml aprotinin, and 10% glycerol. Lysates were centrif uged for 10 min at 15,000 rpm, and supernatants were removed and assayed for protein content. To measure caspase activity, aliquots of cell extracts containing 10 g of protein were added to a reaction buffer (25 mM H EPES at pH 7.4, 10 mM DTT, 10% sucrose, 0.1% CHAPS) (Stefanis et al., 1996) 
Laboratories, Plymouth Meeting, PA) for caspase-1-like protease activity and incubated at 37°C for 2 hr. DEV D-AFC cleavage was measured using an SL M 8000 fluorometer (excitation 400 nm and emission 505 nm), and DEV D-pNA and YVAD-pNA cleavage were measured at 405 nm in a spectrophotometer. Western blot anal ysis. C ells were extracted as above, and aliquots containing 30 g of protein were separated on a 10% acrylamide gel and transferred to a nitrocellulose membrane. After they were blocked for 2 hr with 5% skim milk, membranes were incubated for 1 hr with either a rabbit polyclonal antibody directed against p53 (C M-1; Novacastra Laboratories, Newcastle upon T yne, UK), a mouse monoclonal antibody (mAb) specific for caspase-3 (Merck Frosst Research, Pointe C laireDorval, PQ), LacZ (C appell, Durham, NC), or a goat polyclonal antibody directed against actin (Santa Cruz Biotechnologies, Santa Cruz, CA). After three washes with TPBS (25 mM Na 2 HPO 4 , 5 mM NaH 2 PO 4 , 0.9% NaC l, 0.1% T ween-20), membranes were incubated for 1 hr at 25°C with the appropriate secondary antibody, washed five times for 5 min each in TPBS, and then developed by an enhanced chemiluminescence system according to the manufacturer's instructions (Amersham, Arlington Heights, IL). Immunofluorescence. For immunofluorescence detection of human p53 delivered by adenovirus vectors, neuronal cultures were fixed for 10 min in 4% paraformaldehyde followed by acetone/methanol (1:1) for 1 min. C ells were then washed three times with PBS and incubated at 25°C for 1 hr with a mouse mAb specific for an amino-terminal epitope of human p53 (DO-1; Santa Cruz). After three washes in PBS, cells were incubated for 1 hr at 25°C with a C y3-conjugated goat anti-mouse secondary antibody (Jackson Immunoresearch Laboratories). C ells were then washed three times in PBS, counterstained with Hoechst 33258, and visualized by fluorescent microscopy.
RESULTS p53 induces apoptosis in cultured cerebellar granule neurons
Recombinant adenovirus-mediated delivery of p53 has previously been shown to induce cell death in various post-mitotic neurons Xiang et al., 1996; Jordan et al., 1997) . To determine whether p53 overexpression could induce cell death in cultured cerebellar granule neurons, CGNs were infected at 50 MOI with recombinant adenoviruses carrying an expression cassette for either the human p53 gene (Adp53) or the ␤-galactosidase reporter gene (AdLacZ). The AdLacZ vector was used to determine the efficiency of transduction as well as to assess the effect of viral infection on neuronal viability as described previously . At a virus titer of 50 MOI, Ͼ90% of neurons infected with AdLacZ were found to express high levels of ␤-galactosidase as determined by X-gal staining (Fig. 1) . After 72 hr in culture, uninfected neurons and neurons infected with the control virus AdLacZ displayed healthy cell bodies and an extensive neuritic network (Fig. 2 A, D) . In contrast, neurons infected with Adp53 exhibited obvious signs of cellular degradation, including phase-bright, pyknotic cell bodies as well as blebbing and dissolution of neuritic processes (Fig. 2G ). This cell death was accompanied by a significant increase in the fraction of cells exhibiting chromatin condensation (Fig. 2 B, E, H ) and positive TUN EL labeling (Fig. 2C, F, I ), indicative of an apoptotic mode of cell death.
To confirm that this cell death was associated with increased expression of p53, neurons infected at 50 MOI with either Adp53 or AdLacZ were immunostained with an antibody specific for human p53 to distinguish from endogenous p53. As expected, neurons infected with AdLacZ were not immunoreactive for human p53 (Fig. 3 A, B) , whereas Ͼ80% of the neurons infected with Adp53 exhibited intense immunopositive staining (Fig.  3C, D) . To determine more precisely the extent of transgene expression, cell extracts were prepared from CGN cultures 48 and 72 hr after infection with AdLacZ or Adp53, and the level of p53 protein was assessed by Western blot analysis, this time using an antibody that recognizes both rodent and human p53. These experiments demonstrate that infection with Adp53 resulted in a substantial increase in p53 expression within 48 hr of infection (Fig. 4) . The lack of detectable p53 in extracts from uninfected cells or cells infected with AdLacZ suggests that the endogenous levels of p53 were comparatively small and that the infection process itself did not significantly alter p53 expression in these cells. Taken together, these results indicate that expression of p53 can directly induce apoptotic cell death in cultured cerebellar granule neurons.
Caspase-3 is activated in P53-mediated cell death
Caspase-3 (CPP32) has been implicated as a key player in certain models of neuronal apoptosis (Kuida et al., 1996; Keane et al., 1997) . To determine whether caspase-3 might be involved in p53-mediated neuronal cell death, we measured caspase-3 activity in cell extracts from CGNs after infection with Adp53 by monitoring the cleavage of its colorimetric substrate DEVD-pNA. Neurons infected with Adp53 exhibited a time-dependent increase in caspase-3-like activity relative to control neurons (Fig.  5) . Infection with Adp53 resulted in a threefold increase in caspase-3-like activity at 48 hr and a 14-fold increase at 72 hr as compared with the control virus AdLacZ. Furthermore, Western blot analysis revealed a significant decrease in the level of caspase-3 proenzyme in extracts from neurons infected with Adp53 consistent with its cleavage into active caspase-3 (Fig. 6) . These results suggest that caspase-3 is activated during p53-mediated cell death in cerebellar granule neurons.
To determine whether other effector caspases may also be involved in this pathway, we examined caspase-1 and -2 activity after infection with Adp53. Caspase-1 activity was measured by cleavage of the colorimetric substrate YVAD-pNA. However, no significant increase in caspase-1 activity could be detected at either 48 or 72 hr after infection with Adp53 (Fig. 5B) . Furthermore, Western blot analysis revealed no change in the level of caspase-2 proenzyme levels at either 48 or 72 hr (data not shown). . p53 induces caspase-3-like activity in cerebellar granule neurons. Neurons were infected at 50 MOI with AdLacZ or Adp53 at the time of plating. After 48 and 72 hr, protein was extracted, and caspase activity was measured. A, C aspase-3 like activity determined by measurement of AcDEVD-pNA cleavage. B, C aspase-1 like activity as determined by AcYVAD-pNA cleavage. Activity is shown as fold increase over control (uninfected replicate dishes), and bars represent the mean with error bars indicating SD; n ϭ 3. Each n represents a cell culture derived from a separate experiment. Figure 6 . p53 induces the cleavage of caspase-3 protein in cerebellar granule neurons. C ells were either uninfected or infected with AdLacZ or Adp53 at 50 MOI, and protein was harvested at 48 and 72 hr for Western blot analysis. After SDS-PAGE, protein was transferred to nitrocellulose filters and probed with an antibody specific for mouse caspase-3, and loading was standardized with actin. Note the disappearance of the 32 kd band 72 hr after infection with Adp53.
These results suggest that caspase-1 and -2 are not involved in this cell death pathway.
Bax-deficient neurons are resistant to p53-induced cell death
To determine whether Bax was required in this p53-mediated cell death pathway, cell survival was examined in CGNs derived from Bax wild-type and Bax-deficient mice after infection with either Adp53 or AdLacZ. In Bax ϩ/ϩ neurons, a significant decrease in cell survival could be detected as early as 48 hr after infection with Adp53 (Fig. 7A) . Neuronal cell death continued to increase gradually with time, and by 96 hr there was an approximate 80% loss in neuronal survival. In contrast, Bax Ϫ/Ϫ neurons infected with Adp53 exhibited only a marginal decrease in cell survival relative to AdLacZ controls that remained constant for at least 120 hr after infection. Consistent with this increased resistance, Bax-deficient neurons infected with Adp53 appeared remarkably healthy when examined by light microscopy (Fig. 7B) .
To determine whether this enhanced survival of Bax-deficient neurons was associated with a decrease in apoptotic cell death, Bax ϩ/ϩ and Bax Ϫ/Ϫ neurons were infected with Adp53 or AdLacZ, and the frequency of TUN EL -positive cells was determined after 72 hr. In Bax ϩ/ϩ neurons, infection with Adp53 resulted in a dramatic increase in the frequency of TUNELpositive cells (ϳ70%) in comparison with neurons infected with the control virus AdLacZ (Fig. 8) . In contrast, BaxϪ/Ϫ neurons infected with Adp53 exhibited only a small increase in TUNELpositive cells (ϳ10%) relative to control. The fact that p53-mediated cell death is dramatically reduced in the absence of Bax suggests that Bax must play a prominent role in this cell death pathway.
Bax has been shown to be transcriptionally regulated by p53 Miyashita and Reed, 1995) ,and Bax induction has been observed in certain p53-mdiated cell death paradigms (Selvakumaran et al., 1994; Zhan et al., 1994; Brady et al., 1996) . Therefore, we examined Bax protein expression in wild-type cerebellar granule neurons after infection with Adp53. Interestingly, p53 overexpression did not cause a significant increase in Bax protein levels (data not shown). Therefore, although Bax appears to play a critical role in p53-mediated cell death, this did not appear to involve induction of Bax expression.
Bax is required for p53-induced caspase-3 activation
We next examined caspase-3 activity in Bax ϩ/ϩ and Bax Ϫ/Ϫ neurons after infection with Adp53 to determine whether Bax was required for p53-mediated caspase-3 activation. In Bax ϩ/ϩ neurons, infection with Adp53 resulted in an approximately 13-fold increase in caspase-3 like activity as compared with the control virus AdLacZ (Fig. 9) . This increase in caspase-3 like activity, however, was absent in Bax-deficient neurons (Fig. 9) , indicating that Bax is required for p53-induced caspase-3 activation.
Caspase-3-deficient neurons exhibit increased resistance to P53-induced cell death
Because caspase-3 appears to be the predominant caspase involved in p53-induced cell death, we next asked whether caspase-3 was required in this p53-mediated cell death pathway. Survival was examined in CGNs derived from C PP32 ϩ/ϩ or CPP32 Ϫ/Ϫ mice after infection with Adp53. The genotype of these mice was determined by PCR, and the absence of caspase-3 protein was confirmed by Western blot analysis (Fig. 10) . Similar to Bax-deficient neurons, neurons deficient in caspase-3 were found to be significantly more resistant to p53-induced cell death than their wild-type counterparts (Fig. 11) . However, survival in CPP32 Ϫ/Ϫ neurons infected with Adp53 did eventually decline relative to control cultures infected with AdLacZ (Fig. 11 A) . This indicates that the absence of caspase-3 delays cell death within the first 96 hr, but death will ensue independent of caspase-3. Consistent with the observed decrease in survival, after 72 hr CPP32Ϫ/Ϫ neurons infected with Adp53 exhibited some signs of cell death when examined by light microscopy; however, they appeared significantly more intact than similarly treated CPP32ϩ/ϩ neurons (Fig. 11 B) . These results suggest that although caspase-3 appears to be involved in p53-induced cell death, there may be additional death pathways through which p53 and Bax can mediate their effects.
It has been suggested that caspase-3 is responsible for the activation of endonucleases involved in the internucleosomal DNA fragmentation process that occurs during apoptosis Sakahira et al., 1998) . Therefore, TUN EL labeling was examined in caspase-3-deficient neurons to determine whether apoptotic DNA fragmentation was being blocked in these cells. Consistent with this hypothesis, the fraction of TUNEL -positive cells was significantly decreased in C PP32Ϫ/Ϫ neurons after infection with Adp53 as compared with control neurons infected with AdLacZ (Fig. 12) . Furthermore, most TUNEL -positive neurons in the C PP32Ϫ/Ϫ cultures did not exhibit the characteristic pyknotic nucleus and highly condensed chromatin structure typically observed in wild-type neurons (data not shown).
DISCUSSION
Recent evidence indicates that p53 is a pivotal molecule regulating the death of many cell types, including postmitotic neurons (White, 1996; Hughes et al., 1997) . We therefore examined the molecular mechanisms by which p53 induces apoptosis in neuronal cells. The results of these experiments support a number of conclusions. First, we demonstrate that p53-induced apoptosis in cerebellar granule neurons results in a strong activation of caspase-3. Second, caspase-3 activity and the subsequent cell death induced by p53 is dependent on the presence of Bax. Cells deficient in Bax exhibit normal morphology and little change in survival relative to LacZ controls, despite the presence of p53. Third, in the absence of caspase-3, p53-induced apoptosis is remarkably delayed in cerebellar granule neurons, indicating the involvement of caspase-3. In conclusion, p53-induced cell death in postmitotic neurons involves a Bax-dependent caspase-3 activation that is a key determinant in neuronal cell death.
We and others have shown that adenovirus-mediated p53 gene delivery to postmitotic neurons results in apoptosis X iang et al., 1996; Jordan et al., 1997) . Because of the potential toxicity of adenoviral vectors Easton et al., 1998) in neuronal cells, viral titers must be rigorously controlled, particularly in the context of neuronal apoptosis. Accordingly, we have used a minimal viral titer of 50 MOI that results in 90 -100% infection of cerebellar granule cells with minimal cytotoxic effects. Neurons infected with AdLacZ (50 MOI) exhibit only a slight 10% decrease in survival after 96 hr relative to those infected with Adp53, which exhibited a 65-80% loss of viability. Similarly, AdLacZ infection resulted in only a slight increase in caspase-3 activation, whereas infection with Adp53 produced a 20-to 25-fold enhancement in DEVD cleavage. Thus, we conclude that the cell death and caspase activation induced in cerebellar granule neurons was primarily caused by the delivery of the p53 gene.
To determine whether Bax is essential to induce caspase-3 activation and the death of cerebellar granule neurons, experiments were conducted on Bax-deficient cells. Our results indicated that in the absence of Bax, no significant increase in caspase-3 activation was evident. Furthermore, neurons infected with p53 in the absence of Bax remained viable even after 96 hr. Cell bodies and processes remained intact, with no signs of degeneration, indicating that Bax-deficient cells were protected from p53-induced apoptosis. Previous studies examining p53- Figure 10 . Absence of caspase-3 expression in C PP32 mutant mice. Protein was extracted from brains derived from wild-type (ϩ/ϩ), heterozygous (Ϫ/ϩ), and CPP32 null (Ϫ/Ϫ) mice, and Western blot analysis was performed. Filters were probed with mouse monoclonal antibodies directed against caspase-3 and actin. induced cell death in Bax-deficient cortical neurons demonstrated significant protection at viral titers up to 250 MOI; however, cells infected at higher titers (500 MOI) exhibited significant cell death despite the absence of Bax (X iang et al., 1998) . Thus, the involvement of Bax in p53-induced apoptosis in cortical neurons remains unclear. It is possible that the f unction of Bax in the cell death process could vary depending on the cell type being examined. One advantage of cerebellar granule neurons is that relatively low viral titers (50 MOI) are sufficient to transduce 90 -100% of the cells. Under these conditions, Bax-deficient neurons are clearly protected against p53-induced apoptosis.
It has been proposed that p53-mediates cell death through transcriptional induction of the Bax gene. Consistent with this proposal, the Bax gene has been reported to contain a p53-responsive element within its promoter region Miyashita and Reed, 1995) , and Bax induction has been observed during p53-mediated cell death in certain cell systems (Selvakumaran et al., 1994; Z han et al., 1994; Brady et al., 1996) . Although this study demonstrates that adenovirus-mediated p53 transduction can induce Bax-dependent cell death in cerebellar granule neurons, this does not appear to require upregulation of Bax expression (results not shown). Likewise, it has been reported that Bax protein levels are not elevated during camptothecin-or radiation-induced cell death of cortical and hippocampal neurons, respectively, although cell death was demonstrated to be Bax-dependent X iang et al., 1998) .
The mechanism by which Bax becomes activated in the absence of increased protein levels is not clear. Recent reports, however, have indicated that after exposure to certain apoptotic stimuli Bax is translocated from the cytoplasm to the mitochondrial membrane and that this process is essential for cell death to occur (Wolter et al., 1997; Goping et al., 1998; Z hang et al., 1998) . One hypothesis is that Bax forms pores in the mitochondrial membrane, resulting in depolarization and the consequent release of cytochrome c. C ytoplasmic cytochrome c has been reported to facilitate the interaction between APAF-1 and caspase-9, resulting in the activation of the caspase cascade (Li et al., 1997; Zou et al., 1997) . Bax activity could also be affected by alterations in the activity of Bax binding partners such as Bcl-X L (Oltvai et al., 1993; Merry and Korsmeyer, 1997) . It is believed that Bax promotes cell death when in its homodimeric form but is inactive when heterodimerized with anti-apoptotic family members (Oltvai and Korsmeyer, 1994 ; for review, see Adams and Cory, 1998) . Thus, Bax may be activated indirectly by the downregulation of its anti-apoptotic antagonists.
The results of the present study indicate that p53-mediated activation of caspase-3 is dependent on Bax. Previous studies have shown that Bax is required for caspase activation after potassium withdrawal-induced cell death of cerebellar granule neurons . Furthermore, it has been demonstrated that Bax overexpression itself can induce caspase activation in neuronal cells (Vekrellis et al., 1997; Martinou et al., 1998) . Thus, one possible mechanism by which Bax may function in the p53-mediated cell death pathway is through the activation of caspases. Our finding that caspase-3-like activity was essentially blocked in Bax-deficient neurons is consistent with this interpretation. It should be noted, however, that the Bax mutation results in significantly greater protection against cell death than the caspase-3 null mutation, clearly indicating that Bax has functions beyond the activation of caspase-3-like activity.
The question as to why the Bax mutation is protective against p53-induced apoptosis whereas caspase-3 deficiency results in a delay of apoptosis may be explained by the involvement of multiple caspases. Previous studies have shown that Bax is a key regulator of caspase activation in neuronal cell types Vekrellis et al., 1997) . Thus, it is possible that other caspases may be activated in response to p53-mediated Bax activation, thereby facilitating cell death in the absence of caspase-3. Alternatively, Bax may initiate a caspase-independent death program in caspase-3-deficient cells. Previous studies using pancaspase inhibitors have suggested that Bax can evoke a caspaseindependent program to execute cell death . The fact that caspase-3-deficient neurons eventually die but do not exhibit the typical pyknotic morphology supports the possibility that a caspase-independent death program may be involved.
Neuronal cell death induced by adenovirus-mediated p53 delivery was significantly delayed in caspase-3-deficient neurons. However, caspase-3 does not appear to play an essential role in this death pathway because caspase-3-deficient neurons expressing p53 did eventually die. Unlike CPP32 ϩ/ϩ neurons, CPP32-deficient neurons did not exhibit typical chromatin condensation, suggesting that caspase-3 is involved in the breakdown of the nucleus and DNA fragmentation in neuronal cells. Indeed, one prominent f unction of caspase-3 appears to be in the activation of caspase-activated deoxyribonuclease (CAD). CAD has been implicated as one of the endonucleases responsible for cleavage of DNA into internucleosomal fragments characteristic of apoptosis Sakahira et al., 1998) .
In summary, p53-induced cell death has been shown to occur in response to a wide range of cellular perturbations, including DNA damage, cell cycle deregulation, and more recently, ischemic insult in neurons (for review, see Ko and Prives, 1996; Hughes et al., 1997) . Results from our studies as well as those of other laboratories have demonstrated that p53 expression alone is capable of inducing apoptosis in postmitotic neurons X iang et al., 1996; Jordan et al., 1997) . The mechanisms by which p53 can induce cell death are complex and vary depending on the cell type examined (for review, see Ding and Fisher, 1998) .
To determine the precise mechanism by which p53 f unctions in neuronal cells, we questioned the involvement of Bax, one of the putative regulatory targets for p53 , and caspase-3, a key regulator of neuronal cell death during development (Kuida et al., 1996) . The results of our experiments demonstrate that p53 mediates a Bax-dependent caspase-3 activation in neurons, and that in the absence of caspase-3 a significant delay in neuronal cell death occurs. We therefore show that Bax and caspase-3 are key determinants in the p53 apoptotic signaling cascade in neurons.
